Amanda L. Blackford

A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts

Simeon Springer, Yuxuan Wang, Marco Dal Molin et al. · Gastroenterology · 2015 · 458 citations · Full text

Medicine, Molecular Medicine, Pathology +15

Egr-2 and Egr-3 are negative regulators of T cell activation

M. Safford, Samuel L. Collins, Michael A. Lutz et al. · Nature Immunology · 2005 · 447 citations

Life Sciences, Immunology, Molecular Biology +13

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

Mark Sausen, Rebecca Leary, Siân Jones et al. · Nature Genetics · 2012 · 415 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance

Marcia Irene Canto, Jose Alejandro Almario, Richard D. Schulick et al. · Gastroenterology · 2018 · 401 citations · Full text

Medicine, Oncology, Pathology +16

<i>SMAD4</i> Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer

Amanda L. Blackford, Oscar K. Serrano, Christopher L. Wolfgang et al. · Clinical Cancer Research · 2009 · 371 citations · Full text

Medicine, Genetics, Oncology +17